Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_assertion type Assertion NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_head.
- NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_assertion description "[Simultaneously targeting the RPS6KB1 and CDC2 products phospho-p70S6K/p85S6K and cdc2/cdk1 is very effective in inhibiting DLBCL proliferation and overcoming drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_provenance.
- NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_assertion evidence source_evidence_literature NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_provenance.
- NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_assertion SIO_000772 19223503 NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_provenance.
- NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_assertion wasDerivedFrom befree-2016 NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_provenance.
- NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_assertion wasGeneratedBy ECO_0000203 NP720978.RAobNl5vaIXNUHbIe9USF2By8Osl30-MimNnep1qU6znk130_provenance.